MedPath

Clioquinol

Generic Name
Clioquinol
Brand Names
Locacorten Vioform
Drug Type
Small Molecule
Chemical Formula
C9H5ClINO
CAS Number
130-26-7
Unique Ingredient Identifier
7BHQ856EJ5

Overview

Clioquinol was withdrawn in 1983 due to neurotoxicity.

Indication

Used as a topical antifungal treatment.

Associated Conditions

  • Acne
  • Atopic Dermatitis
  • Contact Dermatitis
  • Dermatosis
  • Eczema impetiginous
  • Eczema of the nuchal nape of the neck
  • Folliculitis
  • Fungal ear infection caused by Aspergillus niger
  • Infantile Eczema
  • Inflammation
  • Intertrigo
  • Lichen simplex chronicus
  • Moniliasis
  • Nummular Dermatitis
  • Otitis Externa
  • Pruritis of the scroti
  • Pruritus Ani
  • Pruritus Vulvae
  • Pyoderma
  • Stasis dermatitis
  • Tinea Capitis
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis
  • Bacterial skin infections
  • Chronic otitis externa
  • Corticosteroid-responsive dermatoses
  • Disseminated Neurodermatitis
  • Localized Neurodermatitis

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
HYDRODERM-C CREAM 1%
SIN08790P
CREAM
3% w/w
7/3/1996
DERMANOL-C CREAM 0.1%
SIN08795P
CREAM
3% w/w
7/3/1996
DERMANOL-C CREAM 0.05%
SIN08796P
CREAM
3% w/w
7/3/1996
DERMANOL-C CREAM 0.025%
SIN08793P
CREAM
3% w/w
7/3/1996

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Clioquinol Cream
国药准字H10940104
化学药品
乳膏剂
12/4/2019

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Locacorten-Vioform Ear Drops
11040
Medicine
A
8/2/1991

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.